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Abstract
Some viruses, such as human immunodeficiency virus, can infect several types of
cell populations. The age of infection can also affect the dynamics of infected cells
and production of viral particles. In this work, we study a virus model with infection-
age and different types of target cells which takes into account the saturation effect
in antibody immune response and a general non-linear infection rate. We construct
suitable Lyapunov functionals to show that the global dynamics of the model is com-
pletely determined by two critical values: the basic reproduction number of virus and
the reproductive number of antibody response.
1 Introduction
In recent times, several mathematical models have been proposed in order to try to under-
stand the mechanism of virus infections. These models often describe the changes through
time in the concentration of infected and uninfected target cells and viral particles in the
blood of an infected individual [1–16]. Modelling the effect of antibody immune response in
the neutralization of virus is a very important topic for research since it can provide useful
insights into the dynamics of the infection and offer suggestions for clinical treatment.
The production of new virions by an infected cell does not occur at a constant rate,
and the death rate of infected cells can vary with the time the cell has been infected. Thus,
the incorporation of an age structure in models allows us to have a more realistic picture
of produced viral particles and the mortality of infected cells; see, for example, the models
studied in [1–6].
A recent work by Duan and Yuan [3] introduced a model with age-structure and
antibody immune response, described by the system
dT (t)
dt
= λ− dT (t)− βT (t)V (t)
1 + αV (t)
∂i(θ, t)
∂θ
+
∂i(θ, t)
∂t
= −δ(θ)i(θ, t)
dV (t)
dt
=
∫ ∞
0
P (θ)i(θ, t) dθ − cV (t)− qA(t)V (t)
dA(t)
dt
=
kA(t)V (t)
h+A(t)
− bA(t),
1
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with the initial and boundary conditions
i(0, t) =
βT (t)V (t)
1 + αV (t)
, T (0) = T0, i(θ, 0) = i0(θ), V (0) = V0, A(0) = A0.
In this model, T, i, V,A denote the concentration of uninfected susceptible host cells, in-
fected host cells, free virus particles, and antibody responses released from B cells, respec-
tively. The variable θ is the infection age, i.e., the time that has elapsed since a virion
has infected a cell, while i(θ, t) is the density of infected T cells with infection age θ at
time t. The functions P (θ) and δ(θ) are respectively the time-since-infection structured
virion production rate and the death rate of productively infected cells. The authors in [3]
showed that the global dynamics of this model is completely determined by the basic
reproduction number R0 and the viral reproductive number R1.
Most mathematical models for human immunodeficiency virus (HIV) focus on the
infection of CD4+ T cells. However, macrophages and dendritic cells are also susceptible
to be infected with HIV [4, 5]. Therefore, we need to incorporate in our virus dynamic
models a multi-group component to study virus infection in different populations of cells.
Viral infection models dealing with the interaction of virus with more than one class of
target cells have been studied in [7–13] and references cited therein.
When modelling the rate of infection of susceptible target cells by contact with virus,
the bilinear incidence term βTV is used frequently in literature [1, 2, 14]. However,
there is certain debate that this rate is insufficient to realistically describe the infection
process. Some authors have incorporated in their models several types of non-linear in-
cidence functions, including saturated Holling type II incidence βTV/(1 + αV ) [3, 5, 15],
Beddington-DeAngelis functional response βTV/(1+aT +bV ) [6, 7], or even more general
functions, e.g., of the forms c(T )f(V ) [16] or h(T, V ) [4, 8, 9].
In this paper, we propose a viral infection model that includes age-structure, multi-
target cells, and a general non-linear rate of viral infection. We establish the global prop-
erties of its equilibria using semigroup methods, uniform persistence and the construction
of Lyapunov functionals.
The rest of this paper is organized as follows: in Section 2 we present the equations
and assumptions for our model, we calculate the basic reproduction number R0 and show
boundedness and non-negativity of solutions. In Section 3 we rewrite the system as a
semilinear Cauchy problem, we prove that the semiflow generated by the system has a
global compact attractor and that it is uniformly persistent when R0 > 1. In Section 4 we
determine the steady states of the system and deal with their local stability. In Section 5
we construct several Lyapunov functionals to determine the global stability of equilibria.
In Section 6 we present a special case in which the model can be reduced to a system of
delay differential equations. In Section 7 we provide some numerical simulations which
illustrate the different kinds of global behaviour the model can have. Finally, in Section 8
we present some concluding remarks.
2 Description of the model
We consider a within-host viral dynamics model for HIV with multiple target cell popu-
lations, which takes into account the saturation effects of antibody immune response and
incorporates a general incidence function hj(Tj , V ). The model is given by the following
2
system of differential equations:
dTj(t)
dt
= λj − djTj(t)− hj(Tj(t), V (t))
∂ij(θ, t)
∂θ
+
∂ij(θ, t)
∂t
= −δj(θ)ij(θ, t)
dV (t)
dt
=
n∑
j=1
∫ ∞
0
Pj(θ)ij(θ, t) dθ − cV (t)− qA(t)V (t)
dA(t)
dt
=
kA(t)V (t)
h+A(t)
− bA(t)
(2.1)
with initial conditions
Tj(0) = T
0
j , ij(θ, 0) = i
0
j (θ), V (0) = V
0, A(0) = A0 (2.2)
and boundary conditions
ij(0, t) = hj(Tj(t), V (t)). (2.3)
This model considers n classes of target cells, denoted by the subscript j = 1, . . . , n. For
each class, Tj represents the population of uninfected target cells, while ij(θ, t) denotes
the population of infected cells with infection age θ at time t. We denote by V the
concentration of free virus particles, and by A the number of antibody responses released
from B cells.
We assume that uninfected cells in the j-th class are recruited at a rate λj and die
at a rate dj . Uninfected cells become infected from contact with the virus according to
the incidence function hj(Tj(t), V (t)). Infected cells in the j-th class die at a rate δj(θ),
which depends on the infection age θ. The function Pj(θ) represents the viral production
rate of an infected cell from the j-th class with infection age θ, while the parameter c is
the viral clearance rate. The virus is removed by the immune system at a rate qA. The
antibody responses are generated by contact with the virus at a rate kA(t)V (t)/(h+A(t))
and vanish at rate b. All parameters are assumed positive.
Furthermore, we assume that the functions δj and Pj satisfy δj , Pj ∈ L∞+
(
(0,∞),R) \
{0L∞} and δj(θ) ≥ δmin > 0 for all θ ≥ 0, j = 1, . . . , n. Let
Pmax = max {ess supPj | j = 1, . . . , n} ,
where ess supPj denotes the essential supremum of Pj(θ) for θ ∈ (0,∞).
We make the following hypotheses on the incidence functions hj , j = 1, . . . , n:
(H1) hj(Tj , V ) = V hj(Tj , V ) with hj , hj ∈ C2
(
R2+ → R+
)
and hj(0, V ) = hj(Tj , 0) = 0
for all Tj , V ≥ 0.
(H2) hj(Tj , V ) is strictly increasing with respect to both variables when Tj , V > 0.
(H3)
∂hj
∂V (Tj , V ) ≤ 0 for all Tj , V ≥ 0 and hj(Tj , V )→ 0 as V →∞.
2.1 Basic reproduction number and boundedness of solutions
For each infected cell in the j-th class, the probability of still being infected after θ time
units is given by
σj(θ) = e
− ∫ θ0 δj(τ) dτ ,
3
so the total number of virions produced by an infected cell from the j-th class in its entire
life span is
Nj =
∫ ∞
0
Pj(θ)σj(θ) dθ.
Hence the corresponding basic reproduction number for system (2.1) when the j-th class
is the unique class of target cells is given by
Rj =
Nj
c
∂hj
∂V
(λj
dj
, 0
)
, j = 1, . . . , n.
Therefore, we can define the basic reproduction number R0 of virus for the model as
R0 =
n∑
j=1
Rj =
1
c
n∑
j=1
Nj
∂hj
∂V
(λj
dj
, 0
)
, (2.4)
which represents the expected number of viruses that one virion produces in a fully unin-
fected cell population.
The second equation of (2.1) is a linear transport equation with decay, so it can be
solved with the initial conditions (2.2) and boundary conditions (2.3) by the method of
integration along the characteristic lines t− θ = constant. The solution is given by
ij(θ, t) =
{
hj
(
Tj(t− θ), V (t− θ)
)
σj(θ) if θ < t,
i0j (θ − t) σj(θ)σj(θ−t) if θ ≥ t,
(2.5)
where σj(θ) = e
− ∫ θ0 δj(τ) dτ .
We will now prove that the model is biologically well-posed by showing the non-
negativity and boundedness properties of the system.
Theorem 2.1. The solutions of system (2.1) with non-negative initial conditions (2.2)
and boundary conditions (2.3) remain non-negative for t ≥ 0 and are positively bounded.
Proof. Let
(
T1, i1, . . . , Tn, in, V, A
)
be a solution of (2.1) with non-negative initial condi-
tions. Suppose that Tj(t) loses its non-negativity for some j and let t0 = inf{t ≥ 0 |
Tj(t) < 0}. By continuity of solutions, we have Tj(t0) = 0 and dTjdt (t0) ≤ 0. But the first
equation of (2.1) implies that
dTj
dt (t0) = λj > 0, a contradiction. Therefore, no such t0
exists and thus, Tj(t) > 0 for all t ≥ 0.
Next, we show that V (t) > 0 and ij(θ, t) ≥ 0 for all t, θ ≥ 0. Define t1 = min
{
inf{t ≥
0 | V (t) < 0}, inf{t ≥ 0 | i1(·, t) /∈ L1+(0,∞)}, . . . , inf{t ≥ 0 | in(·, t) /∈ L1+(0,∞)}
}
.
Suppose first that t1 = inf{t ≥ 0 | ij(·, t) /∈ L1+(0,∞)} for some j. Then (2.5) implies
that ij(θ, t1) ≥ 0 for all θ ≥ 0, which is a contradiction. Hence, t1 = inf{t ≥ 0 | V (t) < 0}.
At the time instant t1, we have
dV
dt (t1) ≤ 0. However, since ij(·, t1) > 0 for all j, the third
equation of (2.1) implies that
dV
dt
(t1) =
n∑
j=1
∫ ∞
0
Pj(θ)ij(θ, t1) dθ > 0,
which leads to a contradiction. Thus, V (t) > 0 and ij(θ, t) ≥ 0 for all t, θ ≥ 0.
Finally, from the last equation of the model we have
A(t) = A(0)e
∫ t
0
(
kV (τ)
h+A(τ)
−b
)
dτ ≥ 0.
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Therefore, the solution remains non-negative on its maximal interval of existence.
Next, we consider the boundedness of solutions. From the first equation of (2.1), we
have
dTj
dt ≤ λj − djTj for j = 1, . . . , n. This implies that
lim sup
t→∞
Tj(t) ≤ λj
dj
.
Let
G(t) =
n∑
j=1
(
Tj(t) +
∫ ∞
0
ij(θ, t) dθ
)
be the total number of cells (uninfected and infected) at time t. Then
dG(t)
dt
=
n∑
j=1
(
dTj(t)
dt
+
∫ ∞
0
∂ij(θ, t)
∂t
dθ
)
=
n∑
j=1
[
λj − djTj(t)− hj(Tj(t), V (t)) +
∫ ∞
0
(
−∂ij(θ, t)
∂θ
− δj(θ)ij(θ, t)
)
dθ
]
≤
n∑
j=1
[
λj − djTj(t)−
∫ ∞
0
δj(θ)ij(θ, t) dθ
]
≤
n∑
j=1
λj −
n∑
j=1
[
djTj(t) + δmin
∫ ∞
0
ij(θ, t) dθ
]
,
since δj(θ) ≥ δmin. Let d = min{d1, . . . , dn, δmin}. Then
dG(t)
dt
≤
n∑
j=1
λj − d
n∑
j=1
[
Tj(t) +
∫ ∞
0
ij(θ, t) dθ
]
=
n∑
j=1
λj − dG(t),
and thus,
lim sup
t→∞
n∑
j=1
∫ ∞
0
ij(θ, t) dθ ≤ lim sup
t→∞
G(t) ≤M,
where M =
(∑n
j=1 λj
)
/d.
Now, from the equation for dVdt in (2.1), we have
dV (t)
dt
≤
n∑
j=1
∫ ∞
0
Pj(θ)ij(θ, t) dθ − cV (t)
≤ Pmax
n∑
j=1
∫ ∞
0
ij(θ, t) dθ − cV (t),
so
dV (t)
dt
≤ PmaxM − cV (t)
when t is large enough. Thus,
lim sup
t→∞
V (t) ≤ PmaxM
c
.
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Finally, from the last equation in (2.1), we have
dA(t)
dt
≤ kV (t)− bA(t) ≤ kPmaxM
c
− bA(t)
for large t, so
lim sup
t→∞
A(t) ≤ kPmaxM
bc
,
which completes the proof of the theorem.
Let
Ω =
{(
T1, i1(·), . . . , Tn, in(·), V, A
) ∈ n∏
j=1
[
R+ × L1+
(
(0,∞),R)]× R2+ |
Tj ≤ λj
dj
,
n∑
j=1
(
Tj +
∫ ∞
0
ij(θ) dθ
)
≤M, V ≤ PmaxM
c
, A ≤ kPmaxM
bc
}
.
Then Ω is a positively invariant set for system (2.1). From now on, we will always assume
that the initial value
(
T 01 , i
0
1(·), . . . , T 0n , i0n(·), V 0, A0
)
is in Ω.
3 Integrated semigroup formulation
We will now reformulate system (2.1) with the initial condition (2.2) as a semilinear
Cauchy problem. In order to take into account also the boundary condition (2.3), we need
to expand the state space as follows. Let
M = R× R× L1((0,∞),R), P = R× {0} × L1((0,∞),R),
N = R× {0} ×W 1,1((0,∞),R), X = ( n∏
i=1
M
)
× R× R,
where W 1,1 denotes a Sobolev space. Consider the linear operator A : Dom(A) ⊂ X → X
given by
A

T1(
0
i1
)
...
Tn(
0
in
)
V
A

=

−d1T1(
i1(0)
−i′1 − δ1(θ)i1
)
...
−dnTn(
in(0)
−i′n − δn(θ)in
)
−cV
−bA

,
with Dom(A) = (∏ni=1 P)× R× R. Then
Dom(A) =
(
n∏
i=1
N
)
× R× R =: X0
6
and we can consider the non-linear map F : X0 → X given by
F

T1(
0
i1
)
...
Tn(
0
in
)
V
A

=

λ1 − h1(T1(t), V (t))(
h1(T1(t), V (t))
0L1
)
...
λn − hn(Tn(t), V (t))(
hn(Tn(t), V (t))
0L1
)
∑n
j=1
∫∞
0 Pj(θ)ij(θ, t) dθ − qA(t)V (t)
kA(t)V (t)
h+A(t)

.
Let
u(t) =
(
T1(t),
(
0
i1(·, t)
)
, . . . , Tn(t),
(
0
in(·, t)
)
, V (t), A(t)
)T
,
P+ = R+ × {0} × L∞
(
(0,∞),R), X0+ = ( n∏
i=1
P+
)
× R+ × R+.
Thus, we can rewrite system (2.1) with the boundary and initial conditions as the following
abstract Cauchy problem:
du(t)
dt
= Au(t) + F(u(t)) for t ≥ 0, with u(0) = x ∈ X0+. (3.1)
By applying the results given in [17] and [18], we can conclude the following theorem.
Theorem 3.1. System (2.1) generates a unique continuous semiflow {U(t)}t≥0 on X0+
that is asymptotically smooth and bounded dissipative. Furthermore, the semiflow {U(t)}t≥0
has a global compact attractor in X0+, which attracts the bounded sets of X0+.
3.1 Uniform persistence
We will now establish the uniform persistence of system (2.1), using arguments that are
highly motivated by those in [6] and [3].
Define
M0 =
(T1, (0, i1), . . . , Tn, (0, in), V, A) ∈ X0+ | V +
n∑
j=1
∫ ∞
0
ij(θ) dθ > 0
 ,
and ∂M0 = X0+ \M0. For j = 1, . . . , n, let ϑj = sup{θ ∈ (0,∞) | Pj(θ) > 0}. Note that
ϑj can possibly be +∞.
Lemma 3.2. ∂M0 is positively invariant under the semiflow {U(t)}t≥0 generated by sys-
tem (2.1). Moreover, the infection-free equilibrium E0 =
(
λ1
d1
, 0, λ2d2 , 0, . . . ,
λn
dn
, 0, 0, 0
)
is globally asymptotically stable restricted to ∂M0.
Proof. Let y ∈ ∂M0 and
(
T1(t), (0, i1(·, t)), . . . , Tn(t), (0, in(·, t)), V (t), A(t)
)
= U(t)y.
Then we have
∂ij(θ, t)
∂θ
+
∂ij(θ, t)
∂t
= −δj(θ)ij(θ, t)
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dV (t)
dt
=
n∑
j=1
∫ ∞
0
Pj(θ)ij(θ, t) dθ − cV (t)− qA(t)V (t)
ij(0, t) = hj(Tj(t), V (t)), ij(θ, 0) = i
0
j (θ),
V (0) = V 0.
Since Tj(t) ≤ λjdj for large t, then ij(θ, t) ≤ i˜j(θ, t) and V (t) ≤ V˜ (t), where (˜i, V˜ ) is the
solution of the system
∂i˜j(θ, t)
∂θ
+
∂i˜j(θ, t)
∂t
= −δj(θ)˜ij(θ, t)
dV˜ (t)
dt
=
n∑
j=1
∫ ∞
0
Pj(θ)˜ij(θ, t) dθ − cV˜ (t)
i˜j(0, t) = hj
(λj
dj
, V˜ (t)
)
, i˜j(θ, 0) = i
0
j (θ)
V˜ (0) = V 0.
(3.2)
From the first and third equation of (3.2), we have
i˜j(θ, t) =
{
hj
(λj
dj
, V˜ (t− θ))σj(θ) if θ < t,
i0j (θ − t) σj(θ)σj(θ−t) if θ ≥ t
(3.3)
and by substituting this expression in the second equation of (3.2), we obtain
dV˜ (t)
dt
=
n∑
j=1
∫ t
0
hj
(λj
dj
, V˜ (t− θ))Pj(θ)σj(θ) dθ + n∑
j=1
F˜j(t)− cV˜ (t), (3.4)
where
F˜j(t) =
∫ ∞
t
Pj(θ)i
0
j (θ − t)
σj(θ)
σj(θ − t) dθ.
For each j, we will prove that F˜j(t) = 0 for all t ≥ 0. In fact, if t ≥ ϑj , then Pj(θ) = 0 for
θ > t ≥ ϑj , so F˜j(t) ≤
∫∞
t Pj(θ)i
0
j (θ − t) dθ = 0. If t < ϑj , then
F˜j(t) ≤
∫ ∞
t
Pj(θ)i
0
j (θ − t) dθ
≤ Pmax
∫ ϑj
t
i0j (θ − t) dθ +
∫ ∞
ϑj
Pj(θ)i
0
j (θ − t) dθ
Since y ∈ ∂M0, then
∫ ϑj
t i
0
j (θ − t) dθ ≤ V 0 +
∑n
j=1
∫∞
0 i
0
j (θ) dθ = 0, and also Pj(θ) = 0
for θ > ϑj , so the two terms in the right-hand side of the aforementioned inequality are
equal to zero. Thus, F˜j(t) ≡ 0. Accordingly, (3.4) is an autonomous equation and has a
unique solution V˜ (t) ≡ 0.
Hence V (t) ≤ V˜ (t) = 0 and dA(t)dt ≤ −bA(t) for large t, which implies that V (t) and
A(t) approach 0 as t→∞. Now, it follows from (3.3) that i˜j(θ, t) = 0 for 0 ≤ θ ≤ t. For
t < θ, we have ∥∥i˜j(θ, t)∥∥L1 = ∥∥∥∥i0j (θ − t) σj(θ)σj(θ − t)
∥∥∥∥
L1
≤ e−δmint ∥∥i0j∥∥L1 .
Therefore, ij(θ, t) → 0 as t → 0. Since ij(θ, t) ≤ i˜j(θ, t), then U(t)y approaches E0 as
t→∞ and the proof is complete.
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Theorem 3.3. If R0 > 1, then the semiflow {U(t)}t≥0 is uniformly persistent with respect
to the pair (∂M0,M0), i.e., there exists  > 0 such that for each y ∈M0,
lim inf
t→∞ d
(
U(t)y, ∂M0
) ≥ .
Furthermore, there exists a compact subset A0 ⊂M0 that is a global attractor for {U(t)}t≥0
in M0.
Proof. Since E0 is globally asymptotically stable in ∂M0, by Theorem 4.2 in [19] we only
need to investigate the behaviour of the solutions starting in M0 in some neighbourhood
of E0. Then, we will show that W s
({E0}) ∩M0 = ∅, where
W s
({E0}) = {y ∈ X0+ | lim
t→∞U(t)y = E
0
}
.
Assume by contradiction that there exists y ∈ W s({E0}) ∩M0. It follows that there
exists t0 > 0 such that V (t0) +
∑n
j=1
∫∞
0 ij(θ, t0) dθ > 0. Using the same argument as in
the proof of Lemma 3.6(i) in [20], we have that V (t) > 0 for t ≥ 0 and ij(θ, t) > 0 for any
θ, t ≥ 0. Define the function
γj(x) =
∫ ∞
x
Pj(θ)e
− ∫ θx δj(τ) dτ dθ.
Note that γj is bounded and satisfies γ
′
j(x) = δj(x)γj(x) − Pj(x) for all x ≥ 0. Consider
the function
Φ(t) =
∫ ∞
0
γj(θ)ij(θ, t) dθ + V (t),
which satisfies
dΦ(t)
dt
= cV (t)
 n∑
j=1
Njhj(Tj(t), V (t))
cV (t)
− qA(t)
c
− 1
 .
Since y ∈ W s({E0}), we have that Tj(t)→ λjdj , V (t)→ 0, and A(t)→ 0 as t→∞. Since
R0 > 1, then
lim
t→∞
 n∑
j=1
Njhj(Tj(t), V (t))
cV (t)
− qA(t)
c
− 1
 = n∑
j=1
Nj
c
∂hj
∂V
(λj
dj
, 0
)− 1 ≥ 0,
so Φ(t) is non-decreasing for sufficiently large t. Thus, there exists t1 > 0 such that
Φ(t) ≥ Φ(t1) for all t > t1. Since Φ(t1) > 0, this prevents the function
(
V (t), ij(·, t)
)
from
converging to (0, 0L1) as t → ∞, which contradicts that Tj(t) → λjdj . This completes the
proof.
4 Steady states and local stability
In this section, we will study the existence and local properties of the steady states for
system (2.1). In order to prove the existence of infected equilibria, we first need to prove
the following results.
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Lemma 4.1. For j = 1, . . . , n, 0 ≤ Tj ≤ λjdj and V ≥ 0, the equation
λj − djTj − hj(Tj , V ) = 0 (4.1)
has a unique solution given by Tj = fj(V ), where fj : R+ →
(
0,
λj
dj
]
is a decreasing function
with fj(0) =
λj
dj
.
Proof. Let ϕ(Tj , V ) = λj − djTj − hj(Tj , V ). If V = 0, it is clear that the only solution
of (4.1) is Tj =
λj
dj
. If V > 0, then assumption (H2) implies that ϕ(Tj , V ) is strictly
decreasing with respect to Tj . Since ϕ(0, V ) = λj > 0 and ϕ(
λj
dj
, V ) < λj − dj(λjdj ) = 0,
then ϕ(Tj , V ) = 0 has a solution Tj = fj(V ) in the interval (0,
λj
dj
), and it is unique due
to monotonicity of ϕ.
Thus, the function fj is well defined and positive. Moreover, differentiation of (4.1)
gives −
(
dj +
∂hj
∂Tj
(Tj , V )
)
dTj − ∂hj∂V (Tj , V ) dV = 0, so
f ′j(V ) =
dTj
dV
= −
(
∂hj
∂V
(Tj , V )
)
/
(
dj +
∂hj
∂Tj
(Tj , V )
)
,
which is negative for V > 0 by assumption (H2), Therefore, fj is decreasing.
Lemma 4.2. The function ψj : R+ → R+ defined by ψj(V ) = hj(fj(V ), V ) is strictly
decreasing for V ≥ 0, and ψj(0) = ∂hj∂V
(λj
dj
, 0
)
.
Proof. Let 0 ≤ V1 < V2. Then fj(V2) < fj(V1) by Lemma (4.1). By (H2) this implies
that hj(fj(V2), V2) < hj(fj(V1), V2), so hj(fj(V2), V2) < hj(fj(V1), V2). By (H3) we also
have that hj is non-increasing with respect to the second variable, so hj(fj(V1), V2) ≤
hj(fj(V1), V1). Therefore, by transitivity, hj(fj(V2), V2) < hj(fj(V1), V1), i.e., ψj(V2) <
ψj(V1). For V = 0, we have
ψj(0) = hj(fj(0), 0) = lim
V→0
hj(fj(0), V )
V
= lim
V→0
hj
(λj
dj
, V
)− hj(λjdj , 0)
V − 0 =
∂hj
∂V
(λj
dj
, 0
)
,
hence the result.
We can now define the viral reproduction number R∗ of model (2.1), which is given by
R∗ =
1
c
n∑
j=1
Njhj
(
fj(
bh
k ),
bh
k
)
(4.2)
and can be interpreted as the average number of antibodies that are activated by the
introduction of a single virion within the host, under the condition that there is no previous
antibody response. Since bhk > 0, Lemma 4.2 implies that hj
(
fj(
bh
k ),
bh
k
)
< hj(fj(0), 0) =
∂hj
∂V
(λj
dj
, 0
)
, and by using the expression in (2.4) for the basic reproduction number R0 we
can see that R∗ < R0.
These two numbers, R0 and R∗, determine whether system (2.1) has one, two, or three
steady states, as asserted in the following theorem.
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Theorem 4.3. System (2.1) always has an infection-free steady state E0 =
(
T 01 , 0, T
0
2 , 0,
. . . , T 0n , 0, 0, 0
)
, where T 0j = λj/dj.
In addition, when R0 > 1, system (2.1) has a unique immune-free infected steady state
E∗ =
(
T ∗1 , i∗1(θ), . . . , T ∗n , i∗n(θ), V ∗, 0
)
, where
T ∗j = fj(V
∗), i∗j (θ) = hj
(
fj(V
∗), V ∗
)
σj(θ),
and V ∗ is the unique positive solution of
n∑
j=1
Njhj
(
fj(V
∗), V ∗
)− c = 0. (4.3)
Also, if R∗ > 1, then system (2.1) has a unique antibody-immune infected steady state
Eˆ =
(
Tˆ1, iˆ1(θ), . . . , Tˆn, iˆn(θ), Vˆ , Aˆ
)
, where
Tˆj = fj(Vˆ ), iˆj(θ) = hj
(
fj(
b
k (h+ Aˆ)),
b
k (h+ Aˆ)
)
σj(θ), Vˆ =
b
k
(h+ Aˆ),
and Aˆ is the unique positive solution of
n∑
j=1
Njhj
(
fj(
b
k (h+ Aˆ)),
b
k (h+ Aˆ)
)− c− qAˆ = 0. (4.4)
Proof. It is clear that for (2.1) the infection-free steady state E0 always exists. To obtain
the immune-free infected steady state E∗, we have to assume that A∗ = 0 and V ∗ 6= 0.
We obtain the system
λj − djT ∗j − hj(T ∗j , V ∗) = 0
di∗j (θ)
dθ
= −δj(θ)i∗j (θ)
n∑
j=1
∫ ∞
0
Pj(θ)i
∗
j (θ) dθ − cV ∗ = 0.
(4.5)
By Lemma 4.1, the solution to the first equation of this system is T ∗j = fj(V
∗), while the
second equation together with the boundary condition (2.3) yields i∗j (θ) = hj(T
∗
j , V
∗)σj(θ) =
hj(fj(V
∗), V ∗)σj(θ). Substituting in the third equation of (4.5), we get
n∑
j=1
∫ ∞
0
Pj(θ)σj(θ)hj(fj(V
∗), V ∗) dθ − cV ∗ = 0
and since V ∗ 6= 0, we can divide the above equation by V ∗ and write it as F (V ∗) = 0 with
F (V ) =
n∑
j=1
Njhj(fj(V ), V )− c.
By Lemma 4.2, the function V → F (V ) is continuous and strictly decreasing for V ≥ 0,
and since lim
V→∞
hj(fj(V ), V ) = 0 by (H3), then
lim
V→∞
F (V ) =
n∑
j=1
Nj lim
V→∞
hj(fj(V ), V )− c = −c < 0.
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This implies that F (V ) = 0 has no positive solutions if F (0) ≤ 0, while it has exactly one
positive solution if F (0) > 0. Since hj(fj(0), 0) = ψj(0) =
∂hj
∂V
(λj
dj
, 0
)
, then
F (0) =
n∑
j=1
Nj
∂hj
∂V
(λj
dj
, 0
)− c = n∑
j=1
Nj
∂hj
∂V
(λj
dj
, 0
)(
1− 1
R0
)
,
so the steady state E∗ exists and is positive if and only if R0 > 1.
For the antibody-immune infected steady state Eˆ, we assume Aˆ 6= 0 and Vˆ 6= 0, so we
obtain the system
λj − dj Tˆj − hj(Tˆj , Vˆ ) = 0
diˆj(θ)
dθ
= −δj(θ)ˆij(θ)
n∑
j=1
∫ ∞
0
Pj(θ)ˆij(θ) dθ − cVˆ − qAˆVˆ = 0
kVˆ
h+ Aˆ
− b = 0.
(4.6)
The last equation of this system implies Vˆ = bk (h+Aˆ). From the first and second equations,
we have Tˆj = fj(Vˆ ) and iˆj(θ) = hj(Tˆj , Vˆ )σj(θ) = hj
(
fj(
b
k (h + Aˆ)),
b
k (h + Aˆ)
)
σj(θ).
Substituting in the third equation of (4.6), we get
n∑
j=1
∫ ∞
0
Pj(θ)σj(θ)hj
(
fj(
b
k (h+ Aˆ)),
b
k (h+ Aˆ)
)
dθ − cVˆ − qAˆVˆ = 0
and since Vˆ 6= 0, this is equivalent to G(Aˆ) = 0, where
G(A) =
n∑
j=1
Njhj
(
fj(
b
k (h+A)),
b
k (h+A)
)− c− qA = 0.
By Lemma 4.2 we know that hj(fj(V ), V ) decreases with respect to V , so A→ G(A)
is a continuous and decreasing function for A ≥ 0. Since V = bk (h + A) tends to infinity
as A→∞ and lim
V→∞
hj(fj(V ), V ) = 0, then
lim
A→∞
G(A) =
n∑
j=1
Nj lim
V→∞
hj(fj(V ), V ) + lim
A→∞
(−c− qA) = −∞.
This implies that G(A) = 0 has no positive solutions if G(0) ≤ 0, while it has exactly one
positive solution if G(0) > 0. We have
G(0) =
n∑
j=1
Njhj
(
fj(
bh
k ),
bh
k
)− c = n∑
j=1
Njhj
(
fj(
bh
k ),
bh
k
)(
1− 1
R∗
)
,
so the steady state Eˆ exists and is positive if and only if R∗ > 1.
The above theorem implies that system (2.1) has only one steady state when R0 ≤ 1,
two steady states when R∗ ≤ 1 < R0 and three when 1 < R∗. We will now analyse their
local stability by means of the characteristic equation of the system.
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Theorem 4.4. The infection-free steady state E0 of system (2.1) is locally asymptotically
stable if R0 < 1 and it is unstable if R0 > 1.
Proof. Using the expression in (2.5) for ij(θ, t), we have∫ ∞
0
Pj(θ)ij(θ, t) dθ
=
∫ t
0
Pj(θ)hj
(
Tj(t− θ), V (t− θ)
)
σj(θ) dθ +
∫ ∞
t
Pj(θ)i
0
j (θ − t)
σj(θ)
σj(θ − t) dθ
=
∫ t
0
kj(θ)hj
(
Tj(t− θ), V (t− θ)
)
dθ + gj(t),
where kj(θ) = Pj(θ)σj(θ) and gj(t) =
∫∞
t Pj(θ)i
0
j (θ − t) σj(θ)σj(θ−t) dθ. Thus, we can rewrite
(2.1) as the following system:
dTj(t)
dt
= λj − djTj(t)− hj(Tj(t), V (t))
dV (t)
dt
=
n∑
j=1
[∫ t
0
kj(θ)hj
(
Tj(t− θ), V (t− θ)
)
dθ + gj(t)
]
− cV (t)− qA(t)V (t)
dA(t)
dt
=
kA(t)V (t)
h+A(t)
− bA(t).
The linearization of this system at E0 is
dTj(t)
dt
= −djTj(t)− ∂hj
∂V
(λj
dj
, 0
)
V (t)
dV (t)
dt
=
n∑
j=1
(
∂hj
∂V
(λj
dj
, 0
) ∫ t
0
kj(θ)V (t− θ) dθ
)
− cV (t)
dA(t)
dt
= −bA(t),
and the characteristic equation is n∏
j=1
(s+ dj)
s+ c− n∑
j=1
(
∂hj
∂V
(λj
dj
, 0
) ∫ ∞
0
kj(θ)e
−sθ dθ
) (s+ b) = 0.
This equation has the negative roots s = −b and s = −dj , j = 1, . . . , n. The rest of its
roots are the solutions of
φ(s) := s+ c−
n∑
j=1
(
∂hj
∂V
(λj
dj
, 0
) ∫ ∞
0
kj(θ)e
−sθ dθ
)
= 0. (4.7)
Suppose that (4.7) has a root s0 with non-negative real part. Then
c ≤ |s0 + c| =
∣∣∣∣∣∣
n∑
j=1
(
∂hj
∂V
(λj
dj
, 0
) ∫ ∞
0
kj(θ)e
−s0θ dθ
)∣∣∣∣∣∣
≤
n∑
j=1
(
∂hj
∂V
(λj
dj
, 0
) ∫ ∞
0
kj(θ)
∣∣∣e−s0θ∣∣∣ dθ) ,
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but ∫ ∞
0
kj(θ)
∣∣∣e−s0θ∣∣∣ dθ ≤ ∫ ∞
0
kj(θ) dθ =
∫ ∞
0
Pj(θ)σj(θ) dθ = Nj ,
so
c ≤
n∑
j=1
(
∂hj
∂V
(λj
dj
, 0
)
Nj
)
= cR0.
This implies that 1 ≤ R0. Therefore, when R0 < 1 all solutions of (4.7) have negative real
part and thus, in such case, E0 is locally asymptotically stable.
Otherwise, if R0 > 1 we have
φ(0) = c−
n∑
j=1
(
∂hj
∂V
(λj
dj
, 0
) ∫ ∞
0
kj(θ) dθ
)
= c(1−R0) < 0,
while φ(s) → ∞ as s → ∞. Then φ(s) has at least one positive real root. Therefore, E0
is unstable when R0 > 1.
We will now study the stability of the immune-free infected steady state E∗. For that,
we define the reproductive number of antibody response RAN as
RAN =
kV ∗
bh
.
We will also need the following result, which shows the relation between RAN and the
viral reproduction number R∗.
Lemma 4.5. R∗ < 1⇔ RAN < 1, R∗ = 1⇔ RAN = 1, and R∗ > 1⇔ RAN > 1.
Proof. Suppose that RAN < 1. Then V
∗ < bhk . Recall that V
∗ satisfies
F (V ∗) =
n∑
j=1
Njhj
(
fj(V
∗), V ∗
)− c = 0.
Since F is strictly decreasing, the condition V ∗ < bhk implies that F
(
bh
k
)
< F (V ∗), i.e.,
n∑
j=1
Njhj
(
fj(
bh
k ),
bh
k
)− c < 0,
that is,
c(R∗ − 1) < 0.
Thus, R∗ < 1. The proof that RAN = 1 =⇒ R∗ = 1 and that RAN > 1 =⇒ R∗ > 1 is
similar, from which the result follows.
Theorem 4.6. The immune-free infected steady state E∗ is unstable when R∗ > 1.
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Proof. The linearization of system (2.1) at E∗ is
dTj(t)
dt
= −
(
dj +
∂hj
∂Tj
(T ∗j , V
∗)
)
Tj(t)− ∂hj
∂V
(T ∗j , V
∗)V (t)
dV (t)
dt
=
n∑
j=1
(
∂hj
∂Tj
(T ∗j , V
∗)
∫ t
0
kj(θ)Tj(t− θ) dθ
)
+
n∑
j=1
(
∂hj
∂V
(T ∗j , V
∗)
∫ t
0
kj(θ)V (t− θ) dθ
)
− cV (t)
dA(t)
dt
=
(
kV ∗
h
− b
)
A(t).
Thus, one of the roots of the characteristic equation is s1 =
kV ∗
h − b. If R∗ > 1, then
RAN =
kV ∗
bh > 1, which implies that s1 is a positive root. Hence the theorem.
5 Global stability
In order to establish the global stability of the equilibrium E0 when R0 ≤ 1, we will make
use of LaSalle’s invariance principle and a Lyapunov functional, similar to those used in
[4] for a multi-target cell model with general incidence.
Theorem 5.1. If R0 ≤ 1, then the infection-free steady state E0 is globally asymptotically
stable.
Proof. Assume R0 ≤ 1. For j = 1, . . . , n, define the function
γj(x) =
∫ ∞
x
Pj(θ)e
− ∫ θx δj(τ) dτ dθ. (5.1)
We will use the Lyapunov functional W = W
(
T1, i1(·, ·), · · · , Tn, in(·, ·), V, A
)
given by
W =
n∑
j=1
Nj
(
Tj − T 0j −
∫ Tj
T 0j
lim
V→0
hj(T
0
j , V )
hj(ηj , V )
dηj
)
+
n∑
j=1
∫ ∞
0
γj(θ)ij(θ, t) dθ + V.
Then W is non-negative and W (E0) = 0. The time derivative of W along the solutions
of (2.1) is
dW
dt
=
n∑
j=1
Nj
(
1− lim
V→0
hj(T
0
j , V )
hj(Tj , V )
)
(λj − djTj − hj(Tj , V ))
−
n∑
j=1
∫ ∞
0
γj(θ)
(
∂ij(θ, t)
∂θ
+ δj(θ)ij(θ, t)
)
dθ
+
n∑
j=1
∫ ∞
0
Pj(θ)ij(θ, t) dθ − cV − qAV
=
n∑
j=1
Nj
(
1− lim
V→0
hj(T
0
j , V )
hj(Tj , V )
)
dj
(
T 0j − Tj
)− n∑
j=1
Nj
(
1− lim
V→0
hj(T
0
j , V )
hj(Tj , V )
)
hj(Tj , V )
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−
n∑
j=1
∫ ∞
0
γj(θ) dij(θ, t)−
n∑
j=1
∫ ∞
0
(
γj(θ)δj(θ)− Pj(θ)
)
ij(θ, t) dθ
− cV − qAV.
Since 0 ≤ Tj ≤ λjdj = T 0j , then hj(Tj , V ) ≤ hj(T 0j , V ) for all V ≥ 0, so 1 ≤ limV→0
hj(T
0
j ,V )
hj(Tj ,V )
.
Thus, we have
(
1− lim
V→0
hj(T
0
j ,V )
hj(Tj ,V )
)(
T 0j − Tj
)
≤ 0 and also −qAV ≤ 0, so
dW
dt
≤ −
n∑
j=1
Nj
(
1− lim
V→0
hj(T
0
j , V )
hj(Tj , V )
)
hj(Tj , V )−
n∑
j=1
∫ ∞
0
γj(θ) dij(θ, t)
−
n∑
j=1
∫ ∞
0
(
γj(θ)δj(θ)− Pj(θ)
)
ij(θ, t) dθ − cV
= −
n∑
j=1
Njhj(Tj , V ) +
n∑
j=1
Njhj(Tj , V ) lim
V→0
hj(T
0
j , V )
hj(Tj , V )
−
n∑
j=1
(
γj(θ)ij(θ, t)
∣∣∣θ=∞
θ=0
−
∫ ∞
0
ij(θ, t)γ
′
j(θ) dθ
)
−
n∑
j=1
∫ ∞
0
(
γj(θ)δj(θ)− P (θ)
)
ij(θ, t) dθ − cV,
where we have used integration by parts to expand
∫∞
0 γj(θ) dij(θ, t). By (5.1) we know
that γj satisfies γ
′
j(x) = δj(x)γj(x)− Pj(x), so
n∑
j=1
∫ ∞
0
ij(θ, t)γ
′
j(θ) dθ −
n∑
j=1
∫ ∞
0
(
γj(θ)δj(θ)− Pj(θ)
)
ij(θ, t) dθ = 0,
and since γj(0) = Nj , then Njhj(Tj , V ) = γj(θ)ij(θ, t)
∣∣
θ=0
. Thus,
dW
dt
≤ −
n∑
j=1
Njhj(Tj , V ) +
n∑
j=1
Njhj(Tj , V ) lim
V→0
hj(T
0
j , V )
hj(Tj , V )
−
n∑
j=1
(
γj(θ)ij(θ, t)
∣∣∣θ=∞
θ=0
)
− cV
=
n∑
j=1
Njhj(Tj , V ) lim
V→0
hj(T
0
j , V )
hj(Tj , V )
−
n∑
j=1
γj(θ)ij(θ, t)
∣∣∣
θ=∞
− cV
= cV
 n∑
j=1
Njhj(Tj , V )
cV
lim
V→0
hj(T
0
j , V )
hj(Tj , V )
− 1
− n∑
j=1
γj(θ)ij(θ, t)
∣∣∣
θ=∞
.
Since 0 ≤ V and hj(Tj , V ) is non-increasing with respect to V , then
hj(Tj , V ) ≤ hj(Tj , 0) = lim
V→0
hj(Tj , V )− hj(Tj , 0)
V
=
∂hj
∂V
(Tj , 0).
We also have
lim
V→0
hj(T
0
j , V )
hj(Tj , V )
= lim
V→0
hj(T
0
j ,V )−hj(Tj ,0)
V
hj(T 0j ,V )−hj(Tj ,0)
V
=
∂hj
∂V
(λj
dj
, 0
)
∂hj
∂V (Tj , 0)
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so
n∑
j=1
Njhj(Tj , V )
cV
lim
V→0
hj(T
0
j , V )
hj(Tj , V )
− 1 =
n∑
j=1
Nj
c
hj(Tj , V )
∂hj
∂V
(λj
dj
, 0
)
∂hj
∂V (Tj , 0)
− 1
≤
n∑
j=1
Nj
c
∂hj
∂V
(λj
dj
, 0
)− 1
= R0 − 1 ≤ 0.
Hence we have dWdt ≤ 0 and the equality holds if and only if Tj = T 0j , ij = 0, V = 0. Thus,
the largest positively invariant subset of the state space where dWdt = 0 is the set
S =
{(
T1, i1(·), . . . , Tn, in(·), V, A
) ∈ Ω | Tj = T 0j , ij(·) = 0, V = 0} .
By LaSalle’s invariance principle, this implies that all solutions with positive initial con-
ditions approach S as t → ∞. On the other hand, any solution of (2.1) contained in S
satisfies dAdt = −bA and thus, A(t) → 0 as t → ∞, that is, the solution approaches E0.
Therefore, we conclude that E0 is globally asymptotically stable in the state space Ω.
We will now use a Lyapunov functional that is constructed as a combination of those
used in [3] and [4] to prove the global stability of E∗.
Theorem 5.2. If R∗ < 1 < R0, then the immune-free infected steady state E∗ is globally
asymptotically stable.
Proof. Consider the Lyapunov functional
W1 =
n∑
j=1
Nj
(
Tj − T ∗j −
∫ Tj
T ∗j
hj(T
∗
j , V
∗)
hj(ξj , V ∗)
dξj
)
+
n∑
j=1
∫ ∞
0
γj(θ)i
∗
j (θ)H
(
ij(θ, t)
i∗j (θ)
)
dθ
+ V ∗H
(
V
V ∗
)
+
qh
k
A,
(5.2)
where H(x) = x− 1− lnx and γj is defined by (5.1). Then this functional is well-defined
based on the uniform persistence of the system. The function H is non-negative and equals
zero only at 1, so it is clear that W1 has a global minimum at the equilibrium E
∗. The
derivative of W1 along the solutions of (2.1) is
dW1
dt
=
n∑
j=1
Nj
(
1− hj(T
∗
j , V
∗)
hj(Tj , V ∗)
)(
λj − djTj − hj(Tj , V )
)
+
n∑
j=1
∫ ∞
0
γj(θ)
(
1− i
∗
j (θ)
ij(θ, t)
)
∂ij(θ, t)
∂t
dθ
+
(
1− V
∗
V
) n∑
j=1
∫ ∞
0
Pj(θ)ij(θ, t) dθ − cV − qAV

+
qh
k
(
kAV
h+A
− bA
)
.
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By (4.3) we have
(
1− V ∗V
)
(−cV ) = c(V ∗ − V ) = ∑nj=1Njhj(T ∗j , V ∗)(V ∗ − V ). Also,
notice that λj = djT
∗
j + hj(T
∗
j , V
∗) and∫ ∞
0
γj(θ)
(
1− i
∗
j (θ)
ij(θ, t)
)
∂ij(θ, t)
∂t
dθ
= −
∫ ∞
0
γj(θ)i
∗
j (θ)
∂
∂t
H
(
ij(θ, t)
i∗j (θ)
)
dθ
= − γj(θ)i∗j (θ)H
(
ij(θ, t)
i∗j (θ)
)∣∣∣∣∣
θ=∞
θ=0
+
∫ ∞
0
H
(
ij(θ, t)
i∗j (θ)
)(
γ′(θ)i∗j (θ) + γj(θ)
di∗(θ)
dθ
)
dθ
= γj(0)i
∗
j (0)H
(
ij(0, t)
i∗j (0)
)
− γj(θ)i∗j (θ)H
(
ij(θ, t)
i∗j (θ)
)∣∣∣∣∣
θ=∞
−
∫ ∞
0
Pj(θ)i
∗
j (θ)H
(
ij(θ, t)
i∗j (θ)
)
dθ
= Njhj(T
∗
j , V
∗)H
(
hj(Tj , V )
hj(T ∗j , V ∗)
)
− γj(θ)i∗j (θ)H
(
ij(θ, t)
i∗j (θ)
)∣∣∣∣∣
θ=∞
−
∫ ∞
0
Pj(θ)i
∗
j (θ)H
(
ij(θ, t)
i∗j (θ)
)
dθ,
since γ′(θ)i∗j (θ) + γj(θ)
di∗(θ)
dθ = −Pj(θ)i∗j (θ), γj(0) = Nj , and ij(0, t) = hj(Tj , V ). Then
we obtain
dW1
dt
=
n∑
j=1
Nj
(
1− hj(T
∗
j , V
∗)
hj(Tj , V ∗)
)(
dj(T
∗
j − Tj) + hj(T ∗j , V ∗)− hj(Tj , V )
)
+
N∑
j=1
[
Njhj(T
∗
j , V
∗)H
(
hj(Tj , V )
hj(T ∗j , V ∗)
)
− γj(θ)i∗j (θ)H
(
ij(θ, t)
i∗j (θ)
)∣∣∣∣∣
θ=∞
−
∫ ∞
0
Pj(θ)i
∗
j (θ)H
(
ij(θ, t)
i∗j (θ)
)
dθ
]
+
n∑
j=1
∫ ∞
0
Pj(θ)ij(θ, t) dθ − V
∗
V
n∑
j=1
∫ ∞
0
Pj(θ)ij(θ, t) dθ
+
n∑
j=1
Njhj(T
∗
j , V
∗)V ∗ −
n∑
j=1
Njhj(T
∗
j , V
∗)V − qAV + qAV ∗ + qhAV
h+A
− qhbA
k
=
n∑
j=1
Njdj(T
∗
j − Tj)
(
1− hj(T
∗
j , V
∗)
hj(Tj , V ∗)
)
−
n∑
j=1
γj(θ)i
∗
j (θ)H
(
ij(θ, t)
i∗j (θ)
)∣∣∣∣∣∣
θ=∞
+
n∑
j=1
Njhj(T
∗
j , V
∗)
(
− hj(T
∗
j , V
∗)
hj(Tj , V ∗)
− hj(Tj , V )
hj(T ∗j , V ∗)
+
hj(Tj , V )
hj(Tj , V ∗)
+
hj(Tj , V )
hj(T ∗j , V ∗)
− ln hj(Tj , V )
hj(Tj , V ∗)
+ ln
hj(T
∗
j , V
∗)
hj(Tj , V ∗)
+ 1− V
V ∗
)
+
n∑
j=1
∫ ∞
0
Pj(θ)i
∗
j (θ)
(
−V
∗ij(θ, t)
V i∗j (θ)
+ 1 + ln
ij(θ, t)
i∗j (θ)
)
dθ
+ qAV
(
h
h+A
− 1
)
+
qA
k
(kV ∗ − bh) .
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By (H2), we know that
hj(T
∗
j ,V
∗)
hj(Tj ,V ∗) < 1 when T
∗
j < Tj and
hj(T
∗
j ,V
∗)
hj(Tj ,V ∗) > 1 when T
∗
j > Tj , so
(T ∗j − Tj)
(
1− hj(T
∗
j ,V
∗)
hj(Tj ,V ∗)
)
≤ 0 for all Tj ≥ 0.
It is clear that γj(θ)i
∗
j (θ)H
(
ij(θ,t)
i∗j (θ)
)∣∣∣
θ=∞
≥ 0. We also have qAV
(
h
h+A − 1
)
≤ 0 since
h ≤ h + A, and qAk (kV ∗ − bh) = qAbhk (RAN − 1) ≤ 0 since the hypothesis R∗ < 1 < R0
implies that RAN < 1. Thus,
dW1
dt
≤
n∑
j=1
Njhj(T
∗
j , V
∗)
(
− hj(T
∗
j , V
∗)
hj(Tj , V ∗)
− hj(Tj , V )
hj(T ∗j , V ∗)
+
hj(Tj , V )
hj(Tj , V ∗)
+
hj(Tj , V )
hj(T ∗j , V ∗)
− ln hj(Tj , V )
hj(Tj , V ∗)
+ ln
hj(T
∗
j , V
∗)
hj(Tj , V ∗)
+ 1− V
V ∗
)
−
n∑
j=1
∫ ∞
0
Pj(θ)i
∗
j (θ)
(
V ∗ij(θ, t)
V i∗j (θ)
− 1− ln ij(θ, t)
i∗j (θ)
)
dθ.
=
n∑
j=1
Njhj(T
∗
j , V
∗)
[
H
(
hj(Tj , V )
hj(Tj , V ∗)
)
−H
(
V
V ∗
)]
−
n∑
j=1
∫ ∞
0
Pj(θ)i
∗
j (θ)H
(
V ∗ij(θ, t)
V i∗j (θ)
)
dθ.
By (H2) and (H3), we have that 0 ≤ V ≤ V ∗ implies VV ∗ ≤
hj(Tj ,V )
hj(Tj ,V ∗) ≤ 1, while
0 ≤ V ∗ ≤ V implies 1 ≤ hj(Tj ,V )hj(Tj ,V ∗) ≤ VV ∗ . Since H(x) = x − 1 − lnx is decreasing for
x ∈ (0, 1) and increasing for x ∈ (1,∞), then H
(
hj(Tj ,V )
hj(Tj ,V ∗)
)
≤ H ( VV ∗ ) for all V ≥ 0. Also,
non-negativity of H implies that Pj(θ)i∗j (θ)H
(
V ∗ij(θ,t)
V i∗j (θ)
)
≥ 0.
Thus, the above argument shows that dW1dt ≤ 0 and that the equality holds if and
only if Tj = T
∗
j , ij(θ, t) = i
∗
j (θ), V = V
∗, and A = 0. Therefore, by LaSalle’s invariance
principle we conclude that E∗ is globally asymptotically stable.
Similarly, inspired in [3] and [4], we make a modification to the Lyapunov functional
(5.2) in order to prove that Eˆ is globally asymptotically stable whenever it exists.
Theorem 5.3. If R∗ > 1, then the antibody-immune infected steady state Eˆ is globally
asymptotically stable.
Proof. Consider the Lyapunov functional
W2 =
n∑
j=1
Nj
(
Tj − Tˆj −
∫ Tj
Tˆj
hj(Tˆj , Vˆ )
hj(ξj , Vˆ )
dξj
)
+
n∑
j=1
∫ ∞
0
γj(θ)ˆij(θ)H
(
ij(θ, t)
iˆj(θ)
)
dθ
+ VˆH
(
V
Vˆ
)
+
q
k
∫ A
Aˆ
(h+ τ)(τ − Aˆ)
τ
dτ,
where H and γj are the same as for (5.2). It can be seen that the term qk
∫ A
Aˆ
(h+τ)(τ−Aˆ)
τ dτ
is positive for A 6= Aˆ and equals zero for A = Aˆ, so W2 has a global minimum at Eˆ. We
calculate the derivative of W2 along the solutions of (2.1) as follows:
dW2
dt
=
n∑
j=1
Nj
(
1− hj(Tˆj , Vˆ )
hj(Tj , Vˆ )
)(
λj − djTj − hj(Tj , V )
)
19
+n∑
j=1
∫ ∞
0
γj(θ)
(
1− iˆj(θ)
ij(θ, t)
)
∂ij(θ, t)
∂t
dθ
+
(
1− Vˆ
V
) n∑
j=1
∫ ∞
0
Pj(θ)ij(θ, t) dθ − cV − qAV

+
q
k
(h+A)(A− Aˆ)
(
kV
h+A
− b
)
.
Following the same steps as in the proof of Theorem 5.2, we obtain
dW2
dt
=
n∑
j=1
Njdj(Tˆj − Tj)
(
1− hj(Tˆj , Vˆ )
hj(Tj , Vˆ )
)
−
n∑
j=1
γj(θ)ˆij(θ)H
(
ij(θ, t)
iˆj(θ)
)∣∣∣∣∣∣
θ=∞
+
n∑
j=1
Njhj(Tˆj , Vˆ )
(
− hj(Tˆj , Vˆ )
hj(Tj , Vˆ )
− hj(Tj , V )
hj(Tˆj , Vˆ )
+
hj(Tj , V )
hj(Tj , Vˆ )
+
hj(Tj , V )
hj(Tˆj , Vˆ )
− ln hj(Tj , V )
hj(Tj , Vˆ )
+ ln
hj(Tˆj , Vˆ )
hj(Tj , Vˆ )
+ 1− V
Vˆ
)
+
n∑
j=1
∫ ∞
0
Pj(θ)ˆij(θ)
(
− Vˆ ij(θ, t)
V iˆj(θ)
+ 1 + ln
ij(θ, t)
iˆj(θ)
)
dθ
− qAV + qAVˆ + q
k
(h+A)(A− Aˆ)
(
kV
h+A
− b
)
.
We have Njdj(Tˆj − Tj)
(
1− hj(Tˆj ,Vˆ )
hj(Tj ,Vˆ )
)
≤ 0 and − γj(θ)i∗j (θ)H
(
ij(θ,t)
i∗j (θ)
)∣∣∣
θ=∞
≤ 0. Since
Vˆ = b(h+ Aˆ)/k, we also have
−qAV + qAVˆ + q
k
(h+A)(A− Aˆ)
(
kV
h+A
− b
)
= −qAV + qAVˆ + qV (A− Aˆ)
− qb
k
(h+A)A+
qb
k
(h+A)Aˆ
= −(A− Aˆ)
[
qb
k
(h+A)− qVˆ
]
=
qb
k
(A− Aˆ)2 ≤ 0,
so
dW2
dt
≤
n∑
j=1
Njhj(Tˆj , Vˆ )
(
− hj(Tˆj , Vˆ )
hj(Tj , Vˆ )
− hj(Tj , V )
hj(Tˆj , Vˆ )
+
hj(Tj , V )
hj(Tj , Vˆ )
+
hj(Tj , V )
hj(Tˆj , Vˆ )
− ln hj(Tj , V )
hj(Tj , Vˆ )
+ ln
hj(Tˆj , Vˆ )
hj(Tj , Vˆ )
+ 1− V
Vˆ
)
−
n∑
j=1
∫ ∞
0
Pj(θ)ˆij(θ)
(
Vˆ ij(θ, t)
V iˆj(θ)
− 1− ln ij(θ, t)
iˆj(θ)
)
dθ
=
n∑
j=1
Njhj(Tˆj , Vˆ )
[
H
(
hj(Tj , V )
hj(Tj , Vˆ )
)
−H
(
V
Vˆ
)]
−
n∑
j=1
∫ ∞
0
Pj(θ)ˆij(θ)H
(
Vˆ ij(θ, t)
V iˆj(θ)
)
dθ
≤ 0.
Thus, dW2dt ≤ 0 and the equality holds if and only if Tj = Tˆj , ij(θ, t) = iˆj(θ), V = Vˆ ,
and A = Aˆ. Therefore, by LaSalle’s invariance principle we conclude that Eˆ is globally
asymptotically stable.
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6 Related models
In this section, we consider a special case in which the model (2.1) can be reduced to
a system of ordinary differential equations with one time delay. For that, we will use
a particular form of incidence rate, which is given by the saturated incidence function
hj(Tj , V ) =
βjTj(t)V (t)
1+αjV (t)
.
We will assume that it takes time τ for virus to enter into the target cell and that
there is an intracellular delay ω that describes the time required for an infected cell to
produce virus, so the death rate of infected cells and viral production rate are given by
the functions
δj(θ) =
{
dj if 0 ≤ θ < τ,
δ∗j if θ ≥ τ
(6.1)
and
Pj(θ) =
{
0 if 0 ≤ θ < ω,
P ∗j if θ ≥ ω.
(6.2)
We also assume that the initial condition ij(θ, 0) = i
0
j (θ) satisfies lim
θ→∞
i0j (θ) = 0, which
means that the initial number of infected cells tends to 0 as the infection age tends to
infinity.
If Ij(t) =
∫∞
0 ij(θ, t) dθ is the number of infected cells in the j-th class at time t, then
dIj(t)
dt
=
∫ ∞
0
∂ij(θ, t)
∂t
dθ
= −
∫ ∞
0
(
∂ij(θ, t)
∂θ
+ δj(θ)ij(θ, t)
)
dθ
= −ij(θ, t)
∣∣∣θ=∞
θ=0
−
∫ ∞
0
δj(θ)ij(θ, t) dθ,
but by (2.5) we have
lim
θ→∞
ij(θ, t) = lim
θ→∞
i0j (θ − t)
σj(θ)
σj(θ − t) = limθ→∞ i
0
j (θ − t)e−δ
∗
j t = 0,
so
dIj(t)
dt
= ij(0, t)−
∫ ∞
0
δj(θ)ij(θ, t) dθ
=
βjTj(t)V (t)
1 + αjV (t)
−
∫ τ
0
djij(θ, t) dθ −
∫ ∞
τ
δ∗j ij(θ, t) dθ.
Using the function (6.2) we obtain∫ ∞
0
Pj(θ)ij(θ, t) dθ = P
∗
j
∫ ∞
ω
ij(θ, t) dθ
= P ∗j
∫ ∞
ω
ij(θ − ω, t− ω)e−δj(θ)ω dθ.
Thus, with these assumptions, the model can be reformulated equivalently as the following
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system:
dTj(t)
dt
= λj − djTj(t)− βjTj(t)V (t)
1 + αjV (t)
dIj(t)
dt
=
βjTj(t)V (t)
1 + αjV (t)
−
∫ τ
0
djij(θ, t) dθ −
∫ ∞
τ
δ∗j ij(θ, t) dθ
dV (t)
dt
=
n∑
j=1
P ∗j
∫ ∞
ω
ij(θ − ω, t− ω)e−δj(θ)ω dθ − cV (t)− qA(t)V (t)
dA(t)
dt
=
kA(t)V (t)
h+A(t)
− bA(t).
(6.3)
In this model we have two intracellular time delays, τ and ω. If we consider the case when
the death rate of infected cells is constant, i.e., δj(θ) = δ
∗
j for all θ ≥ 0, then the above
system can be further simplified to the following system of delay differential equations:
dTj(t)
dt
= λj − djTj(t)− βjTj(t)V (t)
1 + αjV (t)
dIj(t)
dt
=
βjTj(t)V (t)
1 + αjV (t)
− δ∗j Ij(t)
dV (t)
dt
=
n∑
j=1
P ∗j e
−δ∗jωIj(t− ω)− cV (t)− qA(t)V (t)
dA(t)
dt
=
kA(t)V (t)
h+A(t)
− bA(t),
(6.4)
which contains no integral terms and only one time delay. In this case, we have σj(θ) =
e−δ
∗
j θ and Nj = P
∗
j e
−δ∗jω/δ∗j , so the basic reproduction numbers of virus and antibodies
for (6.4) can be calculated as
R0 =
1
c
n∑
j=1
P ∗j e
−δ∗jωλjβj
djδ∗j
, R∗ =
1
c
n∑
j=1
kP ∗j e
−δ∗jωλjβj
δ∗j
(
kdj + (djαj + βj)bh
) .
7 Numerical examples
We will now perform some numerical simulations to illustrate the analytical results ob-
tained for the dynamics of model (2.1).
7.1 Model with one class of target cells
We first simulate the case n = 1 for system (2.1) with the particular forms of δ1(θ) and
P1(θ) used in Section 6 to obtain the simplified system (6.4). Hence, we are considering
a model with intracellular delay ω in viral production, constant death rate δ∗ for infected
cells, and saturated incidence rate. We use the parameters shown in Table 1, which are
similar to those used in [7, 21, 22] for models of HIV infection with only one population
of target cells.
We consider three different values for the infection rate β, given in virions/day, in order
to obtain the three possible scenarios for the dynamics of the model. For each case, we
show the graphs of solutions with respect to time for several initial conditions, which are
given in cells/ml for T (t) and I(t), in virions/ml for V (t), and in µg for A(t).
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Parameter Value Units
λ1 46 cells ·ml−1 · day−1
d1 0.0046 day
−1
α1 0.005 –
δ∗1 0.01 day−1
P ∗1 11.4059 virions · day−1 · cell−1
ω 0.5 days
c 0.25 day−1
q 0.03 µg−1 · day−1
k 0.0015 virion−1 · day−1
h 0.2 –
b 2.9 day−1
Table 1: Parameters used for numerical simulations of system (6.4) with one class of target
cells.
Figure 1: Solutions of system (6.4) when R∗ < R0 < 1 and E0 is globally asymptotically
stable.
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Figure 2: Solutions of system (6.4) when R∗ < 1 < R0 and E∗ is globally asymptotically
stable.
Figure 3: Solutions of system (6.4) when 1 < R∗ < R0 and Eˆ is globally asymptotically
stable.
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We first consider the case when β = 1×10−8, obtaining R0 = 0.4540 and R∗ = 0.1547,
which are less than 1. According to Theorem 5.1, all solutions approach the uninfected
equilibrium E0 as t→∞, as we can see in Figure 1.
For β = 5× 10−8, we have R0 = 2.7238, R∗ = 0.9270, so according to Theorem 5.2 all
solutions converge to the immune-free infected equilibrium E∗, as we can see in Figure 2.
Lastly, if we take β = 5× 10−7, then we have R0 = 22.6980, R∗ = 7.6287, so according
to Theorem 5.3 all solutions converge to the immune infected equilibrium Eˆ, as shown in
Figure 3.
7.2 Model with two classes of target cells
We will now assume that there are two different populations of target cells: CD4+ T cells
(denoted by the subscript j = 1) and macrophages (j = 2).
For the CD4+ T cells, we consider a viral production kernel P1(θ) similar to that used
in [2], which is given by
P1(θ) =
{
0 if 0 ≤ θ < θ1,
P ∗1
(
1− e−r(θ−θ1)) if θ ≥ θ1, ,
where P ∗1 = 6.4201× 103 virions · day−1 · cell−1, while r = 1 is a saturation parameter and
θ1 = 0.25 days is the age at which reverse transcription is completed. We use a death rate
for infected cells δ1(θ) of the form (6.1) with d1 = 0.0046 day
−1, δ∗1 = 1.5 day−1 and a
saturated infection rate h1(T1, V ) =
β1T1V
1+α1V
with α1 = 0.005, β1 = 2.4×10−8 virions·day−1.
For the macrophages, we use a constant death rate δ2(θ) = 1/14.1 day
−1 and we
assume that viral particles at produced at a rate P2(θ) = 0.1 + 10
3×0.00028θ [23]. We
assume that the infection rate is given by the function h2(T2, V ) =
1.19T2V
106+V
[24]. The rest
of the parameters used are given in Table 2 and are based on [2, 7, 23].
Figure 4 shows the solutions for each variable of system (2.1) with the above pa-
rameters, using the initial conditions T1(0) = 5000, T2(0) = 10
6, i1(θ, 0) = i2(θ, 0) =(
1.194× 10−4) e−10θ, V (0) = 0.1, A(0) = 0.1. In this case, the basic reproduction numbers
are R1 = 17.8200 for the population of CD4
+ T cells and R2 = 0.2963 for macrophages,
so the total basic reproduction number of virus is R0 = R1 + R2 = 18.1163. From this,
we can see that the relative contribution of T cells to infection is considerably stronger
than that of macrophages. The viral reproduction number with antibody response is
R∗ = 6.3637. Since R0 > 1 and R∗ > 1, all solutions converge to a positive steady state,
which corresponds to the chronic phase of HIV, as can clearly be seen in the simulations.
8 Conclusions
In this paper, we have studied an age-structured within-host viral dynamic model that
includes multiple populations of target cells. Our model incorporates saturated antibody
immune response and a general non-linear incidence rate, so it can be viewed as a general-
ization of several models that have been studied previously in the literature. This kind of
models can be used to evaluate the relative contribution of viral production from different
compartments of target cells, such as CD4+ cells, macrophages and dendritic cells, and
this can help us improve our understanding of the dynamics of HIV infection.
We have extended the results published in [3], where the authors studied a similar
model with a saturated incidence that did not include multiple classes of target cells.
We proved that the global dynamics of the model is completely determined by the basic
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Parameter Value Units
λ1 10
4 cells ·ml−1 · day−1
d1 0.01 day
−1
λ2 8640 cells ·ml−1 · day−1
d2 0.024 day
−1
c 23 day−1
q 0.03 µg−1 · day−1
k 0.0015 virion−1 · day−1
h 0.2 –
b 2.9 day−1
Table 2: Parameters used for numerical simulations of system (2.1) with two classes of
target cells.
Figure 4: Time evolution of the solution of system (2.1) with two classes of target cells.
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reproduction number and the reproductive number of antibody response. If R0 is less
than one, the only steady state of the model is the infection-free equilibrium and the
infection is predicted to die out. When R∗ < 1 < R0, an infected equilibrium E∗ appears
which is globally asymptotically stable, so infection becomes chronic but with no persistent
antibody immune response. Lastly, if R∗ > 1, the antibody-immune infected equilibrium
Eˆ appears and all solutions converge to it; this case corresponds to the scenario when the
infection becomes chronic with a persistent antibody immune response.
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